arrow_back Trending Legislation
Share share

Easier Access to Lower-Cost Medicines for Seniors in Medicare

This act aims to make it easier for seniors to access lower-cost generic and biosimilar drugs under the Medicare Part D program. Insurance companies will be required to include these drugs in preferred positions on their formularies, potentially lowering patient costs. Restrictions on access to these drugs will be prohibited, ensuring greater availability.
Key points
Medicare Part D insurance plans must include lower-cost generic and biosimilar drugs in preferred positions on their drug lists (formularies).
A preferred position means lower out-of-pocket costs for patients and better access to these medications.
Plans are prohibited from imposing more restrictive limits on access to lower-cost generic and biosimilar drugs than on their more expensive counterparts.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2023
Print number: HR 5461
Sponsor: Rep. Kuster, Ann M. [D-NH-2]
Process start date: 2023-09-14